
Trade Setup for Thursday: Top 15 things to know before Opening Bell Moneycontrol.com
Highest Put unwinding was seen at the strike price of 11700, which shed 11.28 lakh contracts, followed by 11400 which shed 6.16 lakh contracts and 11300 …
Plant and Drug Research Studies
Trade Setup for Thursday: Top 15 things to know before Opening Bell Moneycontrol.com
Highest Put unwinding was seen at the strike price of 11700, which shed 11.28 lakh contracts, followed by 11400 which shed 6.16 lakh contracts and 11300 …
‘Patients say ayahuasca is like a reboot for the brain’ Haaretz
What is it with you and drugs? I did my doctorate under Prof. Raphael Meshulam on the subject of cannabis. The truth is that it’s not something that I was aiming …
Nurse admits diluting patient’s medicine – which caused a 4-year-old to die – to steal for herself Daily Mail
Kristie Ann Mollohan, 40, of Kalamazoo, Michigan pleaded guilty in connection with diluting liquid diazepam (Valium) prescribed to her patients to control their …
Teens taking ‘taxi’ ride to drug addiction Bangkok Post
Teenagers are increasingly using a new concoction derived from a prescription drug for a cheap high, according to the police.
Teen Xanax abuse is surging KTOO
Teen drug use during the summer often goes unnoticed. It’s when school starts and students nod off in class, exchange pills in the hallways and fail tests that the …
How psychedelic drugs might transform how we treat depression and mental illness Vox.com
A conversation with author Michael Pollan on becoming a “reluctant psychonaut.”
FDA approves ‘magic mushroom’ psilocybin therapy trial for treatment-resistant depression OutSourcing-Pharma.com
Compass Pathways has received approval from the US FDA for a clinical trial using psilocybin, the active ingredient in ‘magic mushrooms.’ A Phase IIb study will …
DMT and near-death experiences are similar, study finds Big Think
A new study compares the psychedelic DMT with near-death experiences.
FDA Approves Landmark Psilocybin Trial for Treatment-Resistant Depression MD Magazine
The phase 2b dose-ranging trial will involve 216 patients across 12-15 research sites in North America and Europe, beginning in the UK later this month.
Science is testing claims about psilocybin microdoses, and finding some truth STAT
Psilocybin microdoses have no effect on problem-solving and rational thinking but do improve a form of thinking underlying creativity, a study suggests.